EPISODE · Dec 20, 2021 · 23 MIN
SGLT2 vs GLP1 for Cardiovascular Prevention
Dr. Centor discusses the use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists and the risk for cardiovascular outcomes in routine care patients with diabetes with Dr. Elisabetta Patorno.
Embed this episode
NOW PLAYING
SGLT2 vs GLP1 for Cardiovascular Prevention
0:00
23:05
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Annals On Call Podcast?
This episode is 23 minutes long.
When was this Annals On Call Podcast episode published?
This episode was published on December 20, 2021.
Can I download this Annals On Call Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!